16 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/senaparib-approved-by-nmpa-for-1l-maintenance-therapy-in-ovarian-cancer-302353885.html
11 Apr 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/04/12/2645033/0/en/Junshi-Biosciences-Announces-Phase-3-Clinical-Study-of-Senaparib-for-Advanced-Ovarian-Cancer-Maintenance-Treatment-Following-First-line-Therapy-Met-Primary-Endpoint.html
LOOKING FOR A SUPPLIER?